Company / Operating Margin
Bone Biologics Corp Operating Margin History
FY2017-FY2020 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Margin
-0.2%
FY2020
5-year range
-1.3% / -0.2%
FY2017-FY2020
Trend
+11.5%
vs FY2019
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from -0.3% to -0.2% over the past 2 years.
Based on SEC 10-K filings.
-0.2% in FY2020 with a 3-year CAGR of +1.0%.
Improved from -0.3% to -0.2% over the past 2 years.
Operating Margin over time
Growth rates
- 3-Year Change
- +1.0pp
- 5-Year Change
- -
- 10-Year Change
- -
Key checks
Key Insights
- In FY2020, operating margin increased 11.5% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2020 | -0.2% | +11.5% |
| FY2019 | -0.3% | -4.0% |
| FY2018 | -0.3% | +80.2% |
| FY2017 | -1.3% | - |
As of FY2020 · SEC 10-K · Updated Jun 28, 2026